DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 8.05 0.17%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

59.49 1.88 (3.26%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $59.49 3.26%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $56.31
Previous Close $57.61
Daily Range $56.15 - $61.50
52-Week Range $22.25 - $67.12
Market Cap $7.0B
P/E Ratio -70.26
Dividend (Yield) $0.00 (0.0%)
Volume 2,873,385
Average Daily Volume 3,105,925
Current FY EPS -$0.53

Sector

Healthcare

Industry

Drugs

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary Rss Feed

3 Drugmakers Facing a Pivotal 2015

Isis Pharmaceuticals, PTC Therapeutics, and GW Pharmaceuticals all expect 2015 to be a pivotal year in their drive toward becoming commercially viable entities. Should investors jump in before the catalysts spark?

Isis Pharmaceuticals (ISIS) Showing Signs Of A Dead Cat Bounce Today

Biotech Stocks Sell Off, ETFs Fall Over 5%

Worst Performing Industries For December 23, 2014

Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations

Isis Pharmaceuticals (ISIS) Stock: Weak On High Volume Today

Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape

Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape

IWM, HEZU: Big ETF Inflows

Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half

Jim Cramer's Top Stock Picks: BA MMM ISIS Q

See More ISIS News...

ISIS's Top Competitors

ISIS $59.49 (3.26%)
Current stock: ISIS
AMGN $160.67 (2.00%)
Current stock: AMGN
GILD $91.15 (1.90%)
Current stock: GILD
BIIB $340.89 (1.53%)
Current stock: BIIB